| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918824 | Radiotherapy and Oncology | 2012 | 8 Pages |
Abstract
Physician-rated and patient-rated RISD in head and neck cancer patients treated with (CH) RT cannot be predicted with univariate relationships between the dose distribution in a single organ at risk and an endpoint. Separate predictive models are needed for different endpoints and factors other than dose volume histogram parameters are important as well.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Miranda E.M.C. Christianen, Cornelis Schilstra, Ivo Beetz, Christina T. Muijs, Olga Chouvalova, Fred R. Burlage, Patricia Doornaert, Phil W. Koken, C. René Leemans, Rico N.P.M. Rinkel, Marieke J. de Bruijn, G.H. de Bock, Jan L.N. Roodenburg,